Using iPSCs that are reprogrammed from SMA patients and non-SMA individuals, we found that the differentiation of MNs is not altered by SMN mutation, at least during the first 7 weeks in culture when MNs are functional. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.